Express Pharma

Home
- Drug approvals
- Deals
- Policies
- Technology
- Leadership
- Research
- AYUSH
- Logistics
- Infrastructure
- Marketing
- HR
- Biotech
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
Videos
- Get Updated! Series
Downloads
More
- Contact Us

Likes
Followers
Subscribers
Followers

Likes
Followers
Subscribers
Followers

Sign in

Welcome, Login to your account.

Forget password? Remember me

Login with your Social ID

Sign in

Recover your password.

A password will be e-mailed to you.

Saturday, November 16, 2024
Home
Digital Issue
Advertise With Us
About Us
- Contact Us
- Subscriptions
Submit Press Release
- Contributors Checklist
- Submit Guest Blogs
Network
- HEALTHCARE
- PHARMA
- COMPUTER
- CRN
- TRAVEL
- FOOD & HOSPITALITY
- EF&H EXPO
PRIVACY POLICY

Express Pharma - Express Pharma

Home
- Drug approvals
- Deals
- Policies
- Technology
- Leadership
- Research
- AYUSH
- Logistics
- Infrastructure
- Marketing
- HR
- Biotech
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
Videos
- Get Updated! Series
Downloads
More
- Contact Us

Home » Brand ‘Adfrar’ will be the second biosimilar Adalimumab in the world

Browsing Tag

Brand ‘Adfrar’ will be the second biosimilar Adalimumab in the world

Torrent Pharma launches Adfrar

Usha Sharma Jan 12, 2016

Brand ‘Adfrar’ will be the second biosimilar Adalimumab in the world Ahmedabad-based Torrent Pharma has launched biosimilar…

SIGNUP FREE NEWSLETTER

Leave this field empty if you're human:

Stay With Us

Facebook Likes
Twitter Followers
Youtube Subscribers
Linkedin Follow us

FEATURED VIDEOS

Digital Issue

Express Pharma December 16-31, 2019

Express Pharma December 01-15, 2019

Express Pharma November 16-30, 2019

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

SIGNUP FREE NEWSLETTER

Leave this field empty if you're human:

InfinityLab Stay Safe Purging Bottle

First Name

Last Name

Email

Mobile

Designation

Company Name

Address

City

Pincode

I would like to be contacted by Agilent representative

Yes, I would like to receive email updates about Agilent products, services and events.

Sign in

Home
- Drug approvals
- Deals
- Policies
- Technology
- Leadership
- Research
- AYUSH
- Logistics
- Infrastructure
- Marketing
- HR
- Biotech
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
Videos
- Get Updated! Series
Downloads
More
- Contact Us